---
figid: PMC6027339__biomedicines-06-00038-g001
figlink: /pmc/articles/PMC6027339/figure/biomedicines-06-00038-f001/
number: F1
caption: Oncogenic MyD88 mutations activate the canonical NF-κB pathway. Activation
  of canonical NF-κB signaling can be induced by the triggering of members of the
  IL-1 receptor or the Toll-like receptor family, which localize to the cell surface
  or, in the case of TLR7 and TLR9, to the endosomal compartment. Ligand binding induces
  the recruitment of MyD88 to the activated receptor via its TIR domain and triggers
  subsequent downstream signaling. MyD88 oligomers nucleate the formation of the Myddosome
  which ultimately results in the activation of IRAKs and the recruitment of the E3
  ubiquitin ligase TRAF6. TRAF6 in turn recruits and activates TAK1 which mediates
  activation of the IKK complex resulting in canonical NF-κB activity. The oncogenic
  variant MyD88L265P promotes spontaneous oligomerization and activation of downstream
  signaling independently of receptor stimulation. Mutant MyD88 is denoted with a
  red asterisk. DD, death domain; IL-1R, interleukin-1 receptor; IKK, IκB kinase;
  IRAK, IL-1R-associated kinase; MyD88, myeloid differentiation primary response protein
  88; TAK1, TGFβ-activated kinase 1; TAB1/2, TAK1-binding protein 1/2; TIR; Toll/interleukin-1
  receptor domain; TLR, Toll-like receptor; TRAF6, TNF receptor-associated factor
  6.
pmcid: PMC6027339
papertitle: 'NF-κB Activation in Lymphoid Malignancies: Genetics, Signaling, and Targeted
  Therapy.'
reftext: Paula Grondona, et al. Biomedicines. 2018 Jun;6(2):38.
pmc_ranked_result_index: '45564'
pathway_score: 0.95912
filename: biomedicines-06-00038-g001.jpg
figtitle: Oncogenic MyD88 mutations activate the canonical NFKB pathway
year: '2018'
organisms:
- Helicobacter pylori
ndex: 1e137cd5-dee2-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6027339__biomedicines-06-00038-g001.html
  '@type': Dataset
  description: Oncogenic MyD88 mutations activate the canonical NF-κB pathway. Activation
    of canonical NF-κB signaling can be induced by the triggering of members of the
    IL-1 receptor or the Toll-like receptor family, which localize to the cell surface
    or, in the case of TLR7 and TLR9, to the endosomal compartment. Ligand binding
    induces the recruitment of MyD88 to the activated receptor via its TIR domain
    and triggers subsequent downstream signaling. MyD88 oligomers nucleate the formation
    of the Myddosome which ultimately results in the activation of IRAKs and the recruitment
    of the E3 ubiquitin ligase TRAF6. TRAF6 in turn recruits and activates TAK1 which
    mediates activation of the IKK complex resulting in canonical NF-κB activity.
    The oncogenic variant MyD88L265P promotes spontaneous oligomerization and activation
    of downstream signaling independently of receptor stimulation. Mutant MyD88 is
    denoted with a red asterisk. DD, death domain; IL-1R, interleukin-1 receptor;
    IKK, IκB kinase; IRAK, IL-1R-associated kinase; MyD88, myeloid differentiation
    primary response protein 88; TAK1, TGFβ-activated kinase 1; TAB1/2, TAK1-binding
    protein 1/2; TIR; Toll/interleukin-1 receptor domain; TLR, Toll-like receptor;
    TRAF6, TNF receptor-associated factor 6.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IKBKB
  - CHUK
  - TLR10
  - IL1R1
  - TLR7
  - TAB1
  - TLR6
  - IKBKG
  - NFKB1
  - TLR4
  - IRAK1
  - TLR9
  - TLR3
  - TLR5
  - NR2C2
  - IRAK4
  - TRAF6
  - TAB2
  - TLR8
  - TLR2
  - TLR1
genes:
- word: IKKB
  symbol: IKK-beta
  source: hgnc_alias_symbol
  hgnc_symbol: IKBKB
  entrez: '3551'
- word: IKKA
  symbol: IKK-alpha
  source: hgnc_alias_symbol
  hgnc_symbol: CHUK
  entrez: '1147'
- word: IL-1R/TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR10
  entrez: '81793'
- word: IL-1R/TLR
  symbol: IL1R
  source: hgnc_prev_symbol
  hgnc_symbol: IL1R1
  entrez: '3554'
- word: IL-1R/TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR7
  entrez: '51284'
- word: TAB1
  symbol: TAB1
  source: hgnc_symbol
  hgnc_symbol: TAB1
  entrez: '10454'
- word: IL-1R/TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR6
  entrez: '10333'
- word: IKKY
  symbol: IKK-gamma
  source: hgnc_alias_symbol
  hgnc_symbol: IKBKG
  entrez: '8517'
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: IL-1R/TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR4
  entrez: '7099'
- word: IRAK1
  symbol: IRAK1
  source: hgnc_symbol
  hgnc_symbol: IRAK1
  entrez: '3654'
- word: TLR9
  symbol: TLR9
  source: hgnc_symbol
  hgnc_symbol: TLR9
  entrez: '54106'
- word: IL-1R/TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR3
  entrez: '7098'
- word: IL-1R/TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR9
  entrez: '54106'
- word: IL-1R/TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR5
  entrez: '7100'
- word: TAK1
  symbol: TAK1
  source: hgnc_alias_symbol
  hgnc_symbol: NR2C2
  entrez: '7182'
- word: IRAK4
  symbol: IRAK4
  source: hgnc_symbol
  hgnc_symbol: IRAK4
  entrez: '51135'
- word: TRAF6
  symbol: TRAF6
  source: hgnc_symbol
  hgnc_symbol: TRAF6
  entrez: '7189'
- word: TAB2
  symbol: TAB2
  source: hgnc_symbol
  hgnc_symbol: TAB2
  entrez: '23118'
- word: IL-1R/TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR8
  entrez: '51311'
- word: TLR7
  symbol: TLR7
  source: hgnc_symbol
  hgnc_symbol: TLR7
  entrez: '51284'
- word: IL-1R/TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR2
  entrez: '7097'
- word: IL-1R/TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR1
  entrez: '7096'
chemicals: []
diseases: []
figid_alias: PMC6027339__F1
redirect_from: /figures/PMC6027339__F1
figtype: Figure
---
